Given that circSATB1 modified FKBP8 protein in a post‐transcriptional manner, we treated CRC cells with Cycloheximide (CHX, inhibitor of protein synthesis) and analyzed the half‐life of FKBP8. The gene discussed is FKBP8; the disease is colorectal carcinoma.